RecruitingNCT00136500
Clinical Research in ALS Study
Clinical Research in Amyotrophic Lateral Sclerosis
Sponsor
University of Miami
Enrollment
10,000 participants
Start Date
Feb 1, 2005
Study Type
OBSERVATIONAL
Conditions
Summary
CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- At least 18 years of age.
- Member of at least one of the following categories:
- Individuals affected with ALS or a related neurodegenerative disease (sporadic or familial)
- Unaffected individuals from fALS pedigrees, including pre-symptomatic individuals at genetic risk for ALS or individuals from pedigrees of ALS related diseases.
- Healthy controls
- Able and willing to comply with relevant procedures.
Exclusion Criteria1
- \. Subject has a condition or is in a situation which, in the PI's opinion, could confound the study finding or may interfere significantly with the individual's participation and compliance with the study protocol -- including but not limited to neurological, psychological and/or medical conditions (e.g., multiple sclerosis, neuropathy, myelopathy).
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00136500
Related Trials
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT032251441 location
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT0540732435 locations
Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis
NCT075026771 location
HEALEY ALS Platform Trial - Master Protocol
NCT0429768374 locations
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT072900623 locations